NEI
ELV icon

Northwest & Ethical Investments’s Elevance Health ELV Stock Holding History

Northwest & Ethical Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Sell
4,741
-4,812
-50% -$1.78M 0.04% 223
2026
Q1 		$2.8M Sell
9,553
-2,521
-21% -$829K 0.06% 229
2025
Q4 		$4.23M Sell
12,074
-5,779
-32% -$1.95M 0.1% 193
2025
Q3 		$5.77M Hold
17,853
– – 0.14% 167
2025
Q2 		$6.94M Buy
17,853
+2,265
+15% +$911K 0.17% 153
2025
Q1 		$6.78M Sell
15,588
-11,455
-42% -$4.6M 0.18% 149
2024
Q4 		$9.98M Buy
27,043
+11,066
+69% +$4.63M 0.27% 119
2024
Q3 		$8.31M Sell
15,977
-1,149
-7% -$614K 0.22% 137
2024
Q2 		$9.28M Buy
17,126
+8,281
+94% +$4.38M 0.27% 119
2024
Q1 		$4.59M Sell
8,845
-11,037
-56% -$5.49M 0.13% 181
2023
Q4 		$9.38M Sell
19,882
-987
-5% -$456K 0.29% 115
2023
Q3 		$9.09M Buy
20,869
+17,901
+603% +$8.12M 0.31% 112
2023
Q2 		$1.32M Buy
2,968
+53
+2% +$24.4K 0.04% 270
2023
Q1 		$1.34M Hold
2,915
– – 0.04% 287
2022
Q4 		$1.5M Buy
2,915
+1,120
+62% +$569K 0.05% 270
2022
Q3 		$815K Sell
1,795
-49
-3% -$23.4K 0.03% 310
2022
Q2 		$890K Sell
1,844
-16,376
-90% -$8.1M 0.03% 310
2022
Q1 		$8.95M Sell
18,220
-4,215
-19% -$1.93M 0.29% 103
2021
Q4 		$10.4M Buy
22,435
+930
+4% +$391K 0.31% 98
2021
Q3 		$8.02M Sell
21,505
-5,860
-21% -$2.23M 0.26% 115
2021
Q2 		$10.4M Buy
27,365
+4,128
+18% +$1.58M 0.34% 94
2021
Q1 		$8.34M Buy
23,237
+171
+0.7% +$55K 0.29% 104
2020
Q4 		$7.41M Buy
23,066
+2,210
+11% +$678K 0.28% 111
2020
Q3 		$5.6M Buy
20,856
+910
+5% +$245K 0.25% 124
2020
Q2 		$5.25M Buy
19,946
+5,480
+38% +$1.46M 0.25% 124
2020
Q1 		$3.28M Buy
14,466
+2,090
+17% +$570K 0.19% 148
2019
Q4 		$3.74M Buy
12,376
+2,665
+27% +$733K 0.17% 168
2019
Q3 		$2.33M Sell
9,711
-1,373
-12% -$376K 0.11% 226
2019
Q2 		$3.13M Buy
11,084
+470
+4% +$128K 0.16% 184
2019
Q1 		$3.05M Sell
10,614
-2,090
-16% -$604K 0.16% 182
2018
Q4 		$3.34M Sell
12,704
-7,333
-37% -$2.02M 0.2% 153
2018
Q3 		$5.49M Buy
20,037
+740
+4% +$192K 0.34% 86
2018
Q2 		$4.59M Sell
19,297
-901
-4% -$209K 0.3% 96
2018
Q1 		$4.44M Buy
20,198
+140
+0.7% +$32.9K 0.3% 96
2017
Q4 		$4.51M Buy
20,058
+206
+1% +$43.9K 0.29% 105
2017
Q3 		$3.77M Buy
19,852
+270
+1% +$51.4K 0.23% 119
2017
Q2 		$3.68M Sell
19,582
-8,765
-31% -$1.57M 0.25% 111
2017
Q1 		$4.69M Buy
28,347
+3,059
+12% +$487K 0.32% 77
2016
Q4 		$3.64M Buy
25,288
+2,488
+11% +$333K 0.25% 103
2016
Q3 		$2.86M Buy
+22,800
New +$2.94M 0.2% 118

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northwest & Ethical Investments's ELV Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Elevance Health (ELV) stake by 50% in Q2 2026, selling an estimated $1.78M and leaving 4,741 shares worth $1.83M. The position accounts for 0.04% of the portfolio, ranked #223.

Northwest & Ethical Investments first reported a position in ELV in Q3 2016 and has held it in 40 quarters since. The position peaked at $10.4M in Q2 2021. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Northwest & Ethical Investments held 4,741 shares of Elevance Health worth $1.83M as of Q2 2026.
  • Northwest & Ethical Investments sold 4,812 Elevance Health shares in Q2 2026, an estimated $1.78M.
  • Elevance Health made up 0.04% of Northwest & Ethical Investments's portfolio in Q2 2026, its #223 holding.
  • Northwest & Ethical Investments first reported a position in Elevance Health in Q3 2016 and has held it in 40 quarters since.
  • Northwest & Ethical Investments's Elevance Health position peaked at $10.4M in Q2 2021.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.